|
December 4 - 6, 2008*
Natcher Conference Center
National Institutes of Health
Bethesda, Maryland
*new meeting pattern this year!
Meeting & Hotel Information | Alternate Hotel Information | Program Schedule | Online Registration | Exhibitors
General Information
The 9th Annual Scientific Meeting in urologic oncology will be held
December 4 – 5, 2008 at the Natcher Conference Center on the
campus of the National Institutes of Health. The Society of Urologic
Oncology and the National Cancer Institute’s Urologic Oncology
Program will jointly sponsor this interactive meeting where all
attendees participate in the discussions. State-of-the-art topics on
prostate, kidney and bladder cancer, as well as, strategies in urologic
oncology will be discussed.
Who Should Attend?
- Urological surgeons
- Medical oncologists
- Radiation oncologists
- Research scientists
- Residents / fellows-in-training
Attendee Participation
This meeting is designed to be a discussion of issues among members
of the urologic oncology community at the National Institutes of
Health. All attendees participate in the discussions and, depending
on the session, may present up to two slides.
|
Call for Manuscripts
Urologic Oncology: Seminars and Original Investigations
Urologic Oncology: Seminars and Original Investigations, the official journal of the Society of Urologic Oncology, welcomes manuscripts describing original clinical and laboratory research in all areas of urologic oncology. The journal is indexed in Index Medicus and listed with PubMed and has an international readership.
All manuscripts should be submitted to:
Michael J. Droller, MD
Department of Urology
The Mount Sinai Medical Center
1 Gustav Levy Place, Box 1272
New York, NY 10029
Specific instructions are listed with the journal online at: www.elsevier.com
|
Registration
In order to confirm your registration, we must receive payment by credit
card (Visa or MasterCard) or check (payable to Society of Urologic
Oncology).
Registration Fee
| Early Reg. |
10/31
|
11/21
|
After 11/21
|
| Members: |
$250
|
$300
|
$350
|
| Non Members: |
$395
|
$445
|
$495
|
| Residents/Fellows-in-training/Nurses |
$125
|
$135
|
$145
|
The early registration deadline is October 31, 2008. Please register
using the attached registration form or register online at
www.suonet.org. After October 31, 2008, the early registration pricing
is no longer available. After November 21, 2008, registrations will be
accepted on-site in Bethesda.
Meals
A continental breakfast, lunch and mid-morning snack on both days
of the meeting are included in the registration fee.
Young Urologic Oncologist Dinner
Wednesday, December 3, 2008
Time: 6:00 p.m. − 9:30 p.m.
Location: Hyatt Regency Bethesda
Attire: Business Casual
Membership in the YUO Section of the Society of Urologic Oncology
consists of fellows, scientists, and board certified or eligible physicians
who are members of the SUO and have some post-residency
training in urologic oncology. Membership is limited to the first 7
years after completion of fellowship.
SUO Dinner at the Hyatt Regency Bethesda
Thursday, December 4, 2008
Time: 7:00 p.m. – 10:00 p.m.
Attire: Business casual attire is appropriate
Enjoy dinner with friends and colleagues at the Hyatt Regency
Bethesda. Registration for this is an additional cost of $70.00 per
person ($40.00 for fellows, nurses and residents). On your registration
form, please indicate which menu choice you would like.
• Grilled Beef Tenderloin with Red Wine Reduction
• Gilled Salmon Fillet with Bordelaise Sauce
• Portobello Napoleon with Balsamic Reduction (vegetarian)
Needs and Objectives
Needs:
The goal of this meeting is to increase communication among
urologic oncology researchers and forge a strong relationship
between the National Cancer Institute and the Society of Urologic
Oncology, as well as the Society’s members and others interested in
urologic oncology.
Objectives:
Following participation in this program, attendees will be able to:
- Describe recent advances in robotic and minimally invasive therapies for prostate, kidney and bladder cancer.
- Recognize new methods for active surveillance and focal therapy for patients with localized prostate cancer.
- Report recent advances in targeted systemic therapy of advanced kidney cancer.
- Assess new biomarkers for screening and other predictive markers for bladder cancer.
- Use recent advances in proton beam and brachytherapy for localized prostate cancer.
- Apply current thinking about the role of the urologic
surgeon in the management of patients with kidney cancer who present with metastatic kidney cancer with their kidney in place.
- Recognize recent advances in surgical treatment of patients with localized bladder cancer.
- Describe new approaches for advances adjuvant therapy of advanced kidney cancer.
- Describe new approaches in the role of finasteride in prevention of prostate cancer.
- Recognize new strategies to enhance the role of intravesical chemotherapy in superficial bladder cancer.
- Apply recent advances in management of complications in female cystectomy.
Evaluation of Quality of Activity
The educational quality of the meeting will be assessed with evaluation
questionnaires to be filled out by the participants.
General Disclaimer of the Society of Urologic Oncology, Inc.
The statements and opinions contained in this program are solely
those of the individual authors and contributors and not of the
Society of Urologic Oncology, Inc. The appearance of the advertisements
is not a warranty, endorsement or approval of the products or
services advertised or of their effectiveness, quality or safety. The
content of this publication may contain discussion of off-label uses
of some of the agents mentioned. Please consult the prescribing
information for full disclosure of approved uses. The Society of
Urologic Oncology, Inc., disclaims responsibility for any injury to
persons or property resulting from any ideas or products referred to
in the abstracts or advertisements.
CME Accreditation Statement
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of the University of Oklahoma College of Medicine and the Society of Urologic Oncology. The University of Oklahoma College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Oklahoma College of Medicine designates this educational activity for a maximum of 13.00 AMA PRA Category 1 Credits™.
Physicians should only claim credit commensurate with the extent of their participation in the activity.
Conflict Resolution Statement
The University of Oklahoma College of Medicine, Office of Continuing Medical Education has reviewed this activity’s speaker and planner
disclosures and resolved all identified conflicts of interest, if applicable.
Special Assistance
We encourage participation by all individuals. If you have a disability, advance notification of any special needs will help us better serve you.
Call (847) 264-5901 if you require special assistance to fully participate in the meeting.
Thank you to our 2008 Corporate Supporters
Diamond
Pfizer, Inc.
Emerald
Amgen
Ruby
Dendreon Corporation
|
MEETING & POSTER SESSIONS
The SUO Annual Meeting Scientific session will be held at the Natcher Conference Center, National Institutes of Health (NIH), in Bethesda,
Maryland. The city’s Metro Red Line easily connects the Hyatt Regency Bethesda to the NIH. Please allow additional time to clear security
when entering the NIH for the meeting.
Hotel Accomodations
Participants are responsible for securing their own accommodations.
Listed below is information regarding the Hyatt Regency Bethesda,
where a limited number of hotel rooms are blocked for this meeting.
Hyatt Regency Bethesda (Sold Out)
One Bethesda Metro Center
Bethesda, MD 20814
(301) 657-1234
Fax: (301) 657-6453
Reservations: (301) 657-1234 or
(800) 233-1234
Discounted room rates have been arranged for meeting attendees and
exhibitors. To make reservations, call (301) 657-1234 or toll-free at
(800) 233-1234. Please inform the reservation agent that you are
attending the Society of Urologic Oncology (SUO) 2008 Annual
Meeting, in order to receive the discounted room rate. Reservations
must be made by Thursday, November 6, 2008, to receive the
discount. Check-in time is 3:00 p.m. and check-out time is 12:00 p.m.
Single Occupancy: $239
Double Occupancy: $239
Triple Occupancy: $289
Quadruple Occupancy: $314
*Rates are quoted exclusive of applicable state and local taxes
(currently 13%) or applicable service, or hotel specific fees in effect at
the hotel at the time of the meeting.
Internet Reservations
Visit Hyatt.com to make your reservations online. Be sure to enter the
group code, G-UROM, in order to receive the discounted rate.
Cancellation Policy
Cancellations must be made 24 hours prior to your arrival in order to
receive a refund.
Alternate Hotel Information
Doubletree Hotel & Executive Meeting Center Bethesda
8120 Wisconsin Avenue
Bethesda, MD 20818
301-652-2000
800-222-TREE (Reservations Phone Number)
or
Please click on the following link for online reservations: http://doubletree.hilton.com/en/dt/groups/personalized/WASBHDT-SUO-20081202/index.jhtml.
Please remember to use the Group Code of "SUO" or "The Society of Urologic Oncology" when making your reservations.
Rate: $239.00 single/double
Ground Transportation
Car Rental
Avis Rent-A-Car is the official rental car company for the SUO
meeting. Using this company is not required, but we encourage you
to take advantage of their special offers. You can call Avis at (800)
331-1600 to book your reservation. Special rates are available during
the meeting dates. The car must be returned to the same renting
location or additional surcharges may apply. All rates include
unlimited free mileage.
Weekend daily rates are available from 12:00
p.m. Thursday through Monday at 11:59 p.m. When making your
reservations, please mention the code J901955, along with the
meeting name, Society of Urologic Oncology, to receive discounted
rates. The special rates do not include any state or local surcharges,
tax, optional coverage or gas refueling charges.
Train
Metro Transit is the transit system for Bethesda and the Washington,
DC area. For more information, go to www.wmata.com.
The Hyatt Regency Bethesda is located on the Red Line of the Metro
Transit. Take this one stop to Medical Center; the Natcher Center is
located directly behind this stop. The Red Line also provides easy
access to the free monuments and museums in Washington, DC,
along with the Natcher Conference Center at the National Institutes
of Health.
Directions
TO HYATT REGENCY BETHESDA
From Washington/National Airport (18 miles):
Take George Washington Pkwy West to I-495 North, to Wisconsin
Avenue South. Hotel is on the right, 2 miles.
From Dulles International (18 miles):
Take Dulles Access Road East to I-495 North, to Wisconsin Avenue
South. Hotel is on the right, 2 miles.
From BWI Airport (32 miles):
Take I-95 South to I-495 West towards Silver Spring/Chevy Chase.
Take to Wisconsin Avenue South. Hotel is on right, 2 miles.
TO NATIONAL INSTITUTE OF HEALTH
(FROM HYATT REGENCY BETHESDA)
Turn onto MD-355 N. / Wisconsin Ave. Continue to follow MD-355
N. Turn left onto North Dr. End at 9000 Rockville Pike Bethesda, MD.
Cancellation Policy
Requests for refunds, less a $50 processing fee, must be made in
writing prior to November 20, 2008. No refunds will be made for
meeting registration cancellations after that date or for requests not
received in writing. No exceptions will be made.
For additional meeting information and all cancellation correspondence,
contact the SUO Executive Office at:
Society of Urologic Oncology
Two Woodfield Lake
1100 E. Woodfield Road, Suite 520
Schaumburg, IL 60173
E-mail: info@suonet.org
Website: www.suonet.org
2008 Meeting Exhibitors (as of 11/19/08)
- Aureon Laboratories
- Envisioneering Medical
- Indevus Pharmaceuticals, Inc
- Pfizer, Inc.
Please note that the meeting pattern has changed for the 2008 SUO Annual Meeting
|